TrialJournal of immunotherapy (Hagerstown, Md. : 1997)2013

Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy.

Richard A Morgan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.